Correction
==========

After publication of our article \[[@B1]\] we noted that in Table [1](#T1){ref-type="table"} for Prothrombinex-VF \'Antithrombin and heparin added\' should have been included under the \'Additional information\' column. A copy of the table with the correct information can be found overleaf.

###### 

Composition of PCCs in the World Federation of Hemophilia register of clotting factor concentrates

                                                       International units relative to factor IX                                                                                                          
  ------------------- -------------------------------- ------------------------------------------- -------- ----- -------- ------------------------------------------------------------------------------ ----------------------------------------------------
  Bebulin VH          Baxter BioScience, Austria       120                                         \(13\)   100   100      Vapour heat, 60°C for 10 hours at 190 mbar, then 80°C for 1 hour at 375 mbar   Heparin added
  Beriplex P/N        CSL Behring, Germany             128                                         68       100   152      Pasteurisation at 60°C for 10 hours, and nanofiltration                        Protein C; antithrombin, heparin and albumin added
  Cofact              Sanquin, the Netherlands         56-140                                      28-80    100   56-140   Solvent/detergent and 15 nm nanofiltration                                     Antithrombin added
  KASKADIL            LFB, France                      148                                         40       100   160      Solvent/detergent                                                              Heparin added
  Octaplex            Octapharma, Austria and France   44-152                                      36-96    100   50       Solvent/detergent and nanofiltration                                           Heparin added; low activated factor VII content
  Profilnine SD       Grifols, USA                     148                                         \(11\)   100   64       Solvent/detergent                                                              \-
  Prothrombinex VF    CSL Bioplasma, Australia         100                                         (-)      100   100      Dry heat, 80°C for 72 hours and nanofiltration                                 Antithrombin and heparin added
  Prothromplex T      Baxter BioScience, Austria       100                                         85       100   100      Vapour heat, 60°C for 10 hours at 190 mbar, then 80°C for 1 hour at 375 mbar   Antithrombin and heparin added
  UMAN Complex D.I.   Kedrion, Italy                   100                                         (-)      100   80       Solvent/detergent and dry heat, 100°C for 30 minutes                           Antithrombin and heparin added

Composition of prothrombin complex concentrates (PCCs) listed in the World Federation of Hemophilia register of clotting factor concentrates \[54\], excluding concentrates for national markets only or for which the concentrations of factors relative to factor IX were not available from the relevant product information sheets. Factor VII presented in parentheses for three-factor PCCs.
